Skip to main content
Fig. 4 | Journal of Neuroinflammation

Fig. 4

From: Early-phase administration of human amnion-derived stem cells ameliorates neurobehavioral deficits of intracerebral hemorrhage by suppressing local inflammation and apoptosis

Fig. 4

A hAMSC administration decreases the number of CD11b+CD45+ cells, Ly6C+ and Ly6G+ cells in the ICH lesions. A Representative gating strategy of the flow cytometry for CD11b CD45 Ly6C Ly6G cells. Data were obtained from the ICH lesions at Days 2, 4 and, 8. B The total cell number. C The number of CD11b+CD45+ cells. D The number of CD11b+CD45+Ly6C+Ly6G cells. E The number of CD11b+CD45+Ly6CLy6G+ cells. Data are plotted in mean ± SEM. P values are based on the Wilcoxon test. *P < 0.05 compared with the ICH group

Back to article page